METTL16 Promotes Head and Neck Squamous Cell Carcinoma Progression via m6A ‐Mediated Stabilization of SREBP2 mRNA and Enhanced Cholesterol Biosynthesis
Cancer Medicine · 2026-05 · 15 (5)
DOI: 10.1002/cam4.71917 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 21.05.2026. Verfasst von Xinrui Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, The First People's Hospital of Kunshan, Jiangsu, China. Hauptthemen laut MEDLINE: Sterol Regulatory Element Binding Protein 2, Methyltransferases, Cholesterol, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Kunshan Municipal Key R&D Program.
Abstract (Originalsprache)
N6‐methyladenosine (m6A) modification is a crucial epigenetic event in the development of head and neck squamous cell carcinoma (HNSCC). Here, we show that methyltransferase‐like 16 (METTL16) expression is elevated in the tumor tissues of patients with HNSCC and is associated with poor prognosis. In addition, our data show that METTL16 promotes the proliferation of HNSCC cells in vitro and in vivo by enhancing cholesterol biosynthesis. Mechanistically, METTL16 catalyzes a key transcription factor in cholesterol biosynthesis—sterol regulatory element‐binding transcription factor 2 (SREBP2) m6A modification and then stabilizes SREBP2 mRNA and ultimately elevates SREBP2 mRNA expression in HNSCC cells. Moreover, we validate that METTL16 promotes HNSCC progression dependent on SREBP2 mRNA expression. Overall, our results reveal a novel function of METTL16 in regulating SREBP2 expression, revealing a previously unrecognized METTL16/SREBP2 pathway in HNSCC cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Head and Neck Surgery, The First People's Hospital of Kunshan, Jiangsu, China.
- Department of Otorhinolaryngology, Kunshan Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Jiangsu, China.
ORCID-Profile: Rui Jiang
Förderung
- Kunshan Municipal Key R&D Program
Zitieren
APA
Ma, X., Ding, X., Deng, J., Gao, Q., Liu, H., Yuan, S., Xiao, Z., & Jiang, R. (2026). METTL16 Promotes Head and Neck Squamous Cell Carcinoma Progression via m6A ‐Mediated Stabilization of SREBP2 mRNA and Enhanced Cholesterol Biosynthesis. Cancer Medicine, 15(5). https://doi.org/10.1002/cam4.71917
Vancouver
Ma X, Ding X, Deng J, Gao Q, Liu H, Yuan S, et al. METTL16 Promotes Head and Neck Squamous Cell Carcinoma Progression via m6A ‐Mediated Stabilization of SREBP2 mRNA and Enhanced Cholesterol Biosynthesis. Cancer Medicine. 2026;15(5). doi:10.1002/cam4.71917
BibTeX
@article{Ma2026,
author = {Ma, Xinrui and Ding, Xiaojun and Deng, Jianhua and Gao, Qian and Liu, Huiting and Yuan, Shuo and Xiao, Zhi and Jiang, Rui},
title = {METTL16 Promotes Head and Neck Squamous Cell Carcinoma Progression via m6A ‐Mediated Stabilization of SREBP2 mRNA and Enhanced Cholesterol Biosynthesis},
journal = {Cancer Medicine},
year = {2026},
volume = {15},
number = {5},
doi = {10.1002/cam4.71917}
}
EUVIMED